GlycanAge

About:

Our vision is to make preventive and personalised healthcare the standard of care

Website: https://glycanage.com

Twitter/X: glycanage

Top Investors: Pareto Holdings, Edward Lando, LAUNCHub Ventures, Kadmos Capital, Jon Oringer

Description:

GlycanAge stands at the forefront of the health-tech and longevity sectors, boasting a technology forged from over three decades of rigorous research and analysis of 200,000 testing samples. Utilizing the largest proprietary dataset of human glycome, GlycanAge is pioneering advanced blood biomarkers for the prediction of age-related diseases.

Total Funding Amount:

$4.7M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom

Founded Date:

2020-01-15

Contact Email:

support(AT)glycanage.com

Founders:

Gordan Lauc, Nikolina Lauc

Number of Employees:

11-50

Last Funding Date:

2024-02-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai